BioUtah News
-
BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah
Recursion and University of Utah found incubator to propel new generation of life sciences in the region August…
-
At White House Roundtable, CSL Behring CEO Paul Perreault Urges Plasma Donations to Fight COVID-19
At a July 30 White House Roundtable, plasma industry leader and CSL Behring (CSL) CEO Paul Perreault, urged…
-
Utah Kidney Diagnostics Company Renalytix AI Announces IPO
Exciting news comes our way this week with the announcement by BioUtah member, Renalytix AI (Renalytix), that the…
-
Utah COVID-19 Relief Programs Go Live
Last week, BioUtah News and Events, reported that a number of new grant programs established by the Utah…
-
Recap of Stock Market Update with Monica DiCenso of JP Morgan
After leaving quite an impression to the attendees of the 2020 Entrepreneur and Investor Summit, we brought Monica…
-
BioUtah Joins ‘InUtah’ Campaign
The recently launched statewide ‘In Utah’ campaign encourages protecting public health and economic reactivation as we continue to…
-
New Utah COVID-19 Economic Relief Programs Take Shape
New and improved grant programs, aimed at providing economic support to Utah businesses impacted by COVID-19, are being…
-
BioFire Respiratory Panel with COVID Target Scores CE Mark
BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19…
-
PhotoPharmics Stay-At-Home Trial for People with Parkinson’s
This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of…
-
Johnson & Johnson to Begin COVID-19 Vaccine Clinical Trials in Humans Next Week
Last month, Johnson & Johnson (J&J) announced that its Phase 1/2a in-human clinical trial of its potential COVID-19…
-
Pfizer, BioNTech Get FDA Fast Track Status for COVID-19 Vaccines
U.S. Pfizer and Germany’s BioNTech announced Monday that they have received Fast Track designation from the FDA for…
-
Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE I Study to Enroll up to 15 Patients in the U.S. SALT LAKE CITY – May…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
